European Medicines Agency (EMA)
7 Westferry Circus
Canary Wharf
London
E14 4HB
United Kingdom
Tel: 44-0-20-7523-7600
Website: http://www.ema.europa.eu/ema/
Email: info@ema.europa.eu
850 articles about European Medicines Agency (EMA)
-
Amgen Announces The European Medicines Agency Acceptance Of Kyprolis (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma
2/27/2015
-
Tolero Pharmaceuticals Receives European Medicines Agency Orphan Drug Designation For Alvocidib For The Treatment Of Acute Myeloid Leukemia
2/26/2015
-
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years
2/20/2015
-
aTyr Pharma Inc. Receives European Medicines Agency Orphan Drug Designation For Resolaris In FSHD
2/18/2015
-
THERAVECTYS Obtains Orphan Drug Designation From European Medicines Agency For Its Lentiviral Vector-Based Therapeutic Vaccine Against Adult T-Cell Leukemia And Lymphoma
2/5/2015
-
GVK Biosciences: European Medicines Agency Recommends Suspending Medicines Over Flawed Studies
1/23/2015
-
European Medicines Agency Accepts Samsung Bioepis' Enbrel® Biosimilar Candidate, SB4, For Regulatory Review
1/21/2015
-
PsiOxus Therapeutics Limited Release: European Medicines Agency Grants Positive Opinion For Orphan Drug Status For Ovarian Cancer Oncolytic Vaccine
1/13/2015
-
Regeneron And Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application Has Been Accepted For Review By European Medicines Agency
1/12/2015
-
NephroGenex Announces That European Medicines Agency Supports The Company’s Study Design For Ongoing Trial In Diabetic Nephropathy
1/8/2015
-
AVEO Oncology Receives Confirmation Of Eligibility For Submission Of A Tivozanib Marketing Authorization Application To European Medicines Agency
1/8/2015
-
Shield Therapeutics Announces The Acceptance For Review By The European Medicines Agency Of The Marketing Authorisation Application For Feraccru®
1/7/2015
-
Gamida Cell Ltd.'s NiCord® Receives FDA And European Medicines Agency Orphan Drug Designation
1/6/2015
-
Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The European Medicines Agency
12/23/2014
-
Oncolytics Biotech Inc. Announces Filing For Orphan Designation With The European Medicines Agency For Pancreatic And Ovarian Cancers
12/22/2014
-
Synageva BioPharma Completes Rolling Submission Of Biologics License Application To The FDA For Sebelipase Alfa And Submits Marketing Authorization Application To European Medicines Agency
12/2/2014
-
NPS Pharmaceuticals, Inc. Release: European Medicines Agency Validates Marketing Authorization Application For Natpar® (Parathyroid Hormone (rDNA)) In Hypoparathyroidism
12/2/2014
-
Pharmacyclics, Inc. Release: New IMBRUVICA (ibrutinib) Application Accepted By European Medicines Agency For Waldenstrom's Macroglobulinemia
12/1/2014
-
ImmunoCellular Therapeutics, Ltd Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program
12/1/2014
-
European Medicines Agency Management Board Discusses Next Steps After Judgment Of EU Civil Service Tribunal
12/1/2014